Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 3/20 | 0.37 |
| ▸ | CES1 | P23141 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24681420 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNAMEN1FAAH | |
| SCHEMBL7746021 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNAMEN1FAAH | |
| SCHEMBL7743511 | 0.92 | ACE2 (0.40) | ALDH1A1TSHRLMNAMEN1FAAH | |
| SCHEMBL7746082 | 0.92 | ACE2 (0.44) | ALDH1A1TSHRLMNAMEN1FAAH | |
| SCHEMBL7743439 | 0.92 | ACE2 (0.44) | ALDH1A1TSHRLMNAMEN1FAAH | |
| SCHEMBL7744131 | 0.88 | ACE2 (0.44) | ALDH1A1TSHRLMNAMEN1FAAH | |
| SCHEMBL7743504 | 0.88 | ACE2 (0.40) | ALDH1A1TSHRLMNAMEN1FAAH | |
| SCHEMBL23924161 | 0.88 | ACE2 (0.44) | ALDH1A1TSHRLMNAMEN1FAAH | |
| SCHEMBL7746036 | 0.88 | LMNA (0.32) | LMNA | |
| SCHEMBL8208557 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023152398-A1 | PREPARATION FOR USE IN A METHOD FOR THE TREATMENT AND/OR PREVENTION OF A DISEASE | PANTHERNA THERAPEUTICS GMBH (DE) | 2023-08-17 | — | — | WO | disclosed |